TNDM
$23.91
Tandem Diabetes Care, Inc.
Intraday
Recent News
Why Are Tandem Diabetes (TNDM) Shares Soaring Today
Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 7.8% in the afternoon session after investment firm Piper Sandler upgraded the stock to Overweight from Neutral and increased its price target.
DraftKings, Eli Lilly downgraded: Wall Street's top analyst calls
DraftKings, Eli Lilly downgraded: Wall Street's top analyst calls
1 Surging Stock with Impressive Fundamentals and 2 Facing Challenges
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro developments. As such, investors are taking notice and bidding up shares.
Assessing Tandem Diabetes Care (TNDM) Valuation After Android Expansion For Tandem Mobi
Android expansion opens new chapter for Tandem Diabetes Care (TNDM) Tandem Diabetes Care (TNDM) is back in focus after announcing that its Tandem Mobi automated insulin delivery system can now be controlled from compatible Android smartphones through the Tandem Mobi mobile app in the US. The Android rollout, which was cleared by the US Food and Drug Administration in November 2025 and initially released on a limited basis in December 2025, broadens access beyond iOS users and could influence...
How Investors Are Reacting To Tandem Diabetes Care (TNDM) Expanding Mobi Control To Android Smartphones
In March 2026, Tandem Diabetes Care announced that its Tandem Mobi automated insulin delivery system can now be controlled via the Tandem Mobi mobile app on compatible Android smartphones in the U.S., following U.S. Food and Drug Administration clearance in November 2025 and a limited release in December 2025. This Android rollout meaningfully broadens access and convenience for Tandem Mobi users, strengthening Tandem Diabetes Care’s position in smartphone-based diabetes management...